Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-21
    E.g., 2018-06-21


12157 items
7:05 AM, Jun 07, 2018  |  BC Extra | Financial News

Follow-on roundup: ImmunoGen, Mirati, Zymeworks, Viking, OptiNose

ImmunoGen Inc. (NASDAQ:IMGN), Mirati Therapeutics Inc. (NASDAQ:MRTX), Zymeworks Inc. (NYSE:ZYME; TSX:ZYME), Viking Therapeutics Inc. (NASDAQ:VKTX) and OptiNose Inc. (NASDAQ:OPTN) each priced follow-ons, raising a total of more than $465 million. ImmunoGen raised $150.7 million through the...
6:13 AM, Jun 07, 2018  |  BC Extra | Financial News

Madrigal, Deciphera raise money after readouts

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) and Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH) each priced upsized offerings late Wednesday. Each company's stock has risen sharply in recent days after auspicious data readouts. Madrigal raised $300 million through the sale of...
12:48 PM, Jun 06, 2018  |  BC Extra | Financial News

Metacrine raises $65M series C

Metacrine Inc. (San Diego, Calif.) raised $65 million in an untranched series C round led by Venrock Healthcare. New investors Franklin Templeton Investments, Deerfield Management, Arrowmark Partners, Invus, Lilly Asia Ventures and Vivo Capital also...
12:26 PM, Jun 06, 2018  |  BC Extra | Financial News

Just China raises $35M ahead of global trials

Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by Hillhouse Capital. Existing investors Temasek, Lilly Asia Ventures, Arch Venture Partners, Taikang and BOCGI Zheshang Capital...
8:20 AM, Jun 06, 2018  |  BC Extra | Financial News

Hua Medicine planning Hong Kong IPO

Diabetes company Hua Medicine Ltd. (Shanghai, China) filed for an IPO on the Hong Kong stock exchange underwritten by Goldman Sachs and CLSA Capital Markets. Hua is the second biotech company to file for a Hong...
5:01 AM, Jun 06, 2018  |  BC Extra | Financial News

Pfizer allocates $600M to venture, with neuroscience a focus

Pfizer Inc. (NYSE:PFE) said it will invest $600 million in biotech and other emerging growth companies via Pfizer Ventures, with about $150 million devoted to early stage neuroscience companies. Pfizer said initial areas of interest...
3:39 PM, Jun 05, 2018  |  BC Extra | Financial News

Madrigal looks to raise $200M after NASH data

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) proposed postmarket Tuesday to raise $200 million on the back of non-alcoholic steatohepatitis data that saw the stock gain 145% last Thursday. The data showed MGL-3196 led to significant improvements vs....
6:47 AM, Jun 05, 2018  |  BC Extra | Financial News

Tricida files for $150M IPO

Renal disease company Tricida Inc. (South San Francisco, Calif.) filed to raise up to $150 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan and Cowen. In 2H19, Tricida plans to submit an...
4:00 AM, Jun 05, 2018  |  BC Extra | Financial News

Nimbus raises $65M to build pipeline

Nimbus Therapeutics LLC (Cambridge, Mass.) raised $65 million in a financing led by existing investor Atlas Venture. Also participating were existing investors SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger. Since...
2:51 PM, Jun 04, 2018  |  BC Extra | Financial News

OrbiMed Asia leads Laekna's $18.5M series A

Laekna Therapeutics Shanghai Co. Ltd. (Shanghai, China) raised $18.5 million in a series A round led by OrbiMed Asia, with participation from AnlongMed. Laekna said it has three candidates in Phase I-II testing to treat...